Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.

Authors:
Shi K; Li M.

Journal:
Pharm Res

Publication Year: 2023

DOI:
10.1007/s11095-023-03532-x

PMCID:
PMC10447287

PMID:
37188904

Journal Information

Full Title: Pharm Res

Abbreviation: Pharm Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestThe authors have no conflicts of interest to declare. Conflict of Interest The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding The project was funded by the UK Engineering and Physical Sciences Research Council (EPSRC, EP/V047329/1). We are also grateful for the in kind support from industrial partners, i.e., Charnwood Molecular Ltd, Almac Group (UK), GMPharma Limited, Simcyp Limited, and Structure Vision Ltd, for the work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025